CNE100001R58
CNE100001R58
WOLWO PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 10.47B EUR | 12.21B EUR | 13.45B EUR |
Enterprise Value | 9.12B EUR | 11.34B EUR | 12.62B EUR |
Valuation Multiples | |||
Trailing P/E | 24.99x | 34.67x | 40.46x |
Forward P/E | 19.6x | -- | -- |
Price to Sales | 9.58x | 12.47x | 14.21x |
Price to Book | 3.8x | 4.43x | 4.91x |
EV/Revenue | 8.35x | 11.58x | 13.34x |
EV/EBITDA | 19.13x | 28.83x | 34x |
Price to FCF (P/FCF) | 47.95x | 33.73x | 48.73x |
EV/FCF | 41.77x | 31.32x | 45.73x |
FCF Yield | 2.09% | 2.96% | 2.05% |